30.07
Hemab Therapeutics Holdings Inc (COAG) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 |
| 期間の長さ | 3 か月 | 3 か月 |
|
|
10.45%
26.08
|
23.61 |
| Operating Income/Loss |
10.45%
-26.08
|
-23.61 |
| Income/Loss From Continuing Operations Before Tax |
6.08%
-24.05
|
-22.68 |
| Income Tax Expense/Benefit |
708.33%
0.097
|
0.012 |
| Net Income/Loss |
6.45%
-24.15
|
-22.69 |
| Basic Average Shares |
3,083%
30.11
|
0.946 |
| Diluted Average Shares |
3,083%
30.11
|
0.946 |
| Basic Earnings Per Share |
96.66%
-0.80
|
-23.98 |
| Diluted Earnings Per Share |
96.66%
-0.80
|
-23.98 |
大文字化:
|
ボリューム (24 時間):